Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ConsCIOUS-3 dexmedetomidine for intubation during general anaesthesia
ACTRN12622000754741Phase 3Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Dexmedetomidine with Placebo saline control (2 arms). Primary endpoint: Depth of anaesthesia assessed by Bispectral Index. Started May 2022; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ACTRN12622000754741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000754741.